Search Results

Press Releases

CellFE® and Syenex Collaborate to Advance Cell Engineering with Hybrid Gene Editing Workflow

January 10, 2025

·

3 min read

Press Releases

CellFE® Announces Launch of First-in-Class T-Rest™ (“Resting T Cell Kit”) for Breakthrough CAR-T Cell Therapy Manufacturing

January 23, 2025

·

3 min read

Biotech Bay

CellFE Announces January 2024 Conference Presentations

CellFE Inc., a life sciences tools company commercializing a microfluidics-based cellular engineering platform, today announced its CEO Alla Zamarayeva, PhD, will be presenting at two conferences in January.

December 20, 2023

·

1 min read

Biotech Bay

CellFE announces launch of novel microfluidic cellular engineering platform at ASGCT 2023 Annual Meeting

CellFE Inc. announced the commercial availability of its Infinity Mtx™ cellular engineering platform, which uses rapid cell compression and re-expansion to actively transport a target payload into the cell.

May 10, 2023

·

2 min read

Drug Development

Cellf BIO Begins Phase 1 Clinical Trial of BioSphincter™ Implant for Fecal Incontinence

Cellf BIO, a biotechnology company that manufactures bioengineered sphincters using autologous progenitor cells, announced today that it has begun its Phase 1 clinical trial for its BioSphincter™ Implant for the treatment of severe passive fecal incontinence (FI).

January 5, 2023

·

3 min read

Deals

CellFE Secures $4.8M Seed Round Funding Co-led by Dynamk Capital and Cota Capital

CellFE, Inc., an innovative startup developing a microfluidics based device to deliver gene-editing molecules, announced it has completed a $4.8 million Series Seed round of financing.

March 31, 2020

·

3 min read

Deals

CellFE Raises $3.6M in Seed Round Co-led by Cota Capital and Dynamk Capital

CellFE, Inc., an innovative startup developing a microfluidics based device to deliver gene-editing molecules, announced it has raised $3.6 million in an initial Series Seed.

January 16, 2020

·

4 min read

Business

Kytopen announces appointment of industry executive Kevin Gutshall as Chief Commercial Officer

Kytopen Corp. today announced the appointment of Kevin Gutshall as Chief Commercial Officer, effective April 1st, 2024.

April 8, 2024

·

2 min read

Press Releases

Microfluidics Market Size to Reach Around USD 110.40 Billion by 2034 | Precedence Research

July 16, 2024

·

8 min read

Mikra Cellular Sciences Receives $8.5 Million in Funding to Launch Novel Therapeutic Product

Mikra Cellular Sciences Inc. (“Mikra”), a biosciences company driving breakthrough applications of bioactive compounds to positively impact human health and intervene before pharmaceuticals are necessary, today announced $8.5 million in funding from its parent company, Lifeist Wellness Inc.

March 9, 2022

·

3 min read